Literature DB >> 7648376

Selective deficiency in pneumococcal antibody response in children with recurrent infections.

M M Epstein1, F Gruskay.   

Abstract

BACKGROUND: Impaired ability to respond to polysaccharide capsular antigens of Streptococcus pneumoniae may be associated with an IgG subclass deficiency and recurrent respiratory infections.
OBJECTIVE: To identify children over three years of age with recurrent otitis media, sinusitis, or pneumonia who had low or absent pneumococcal antibody titers as their sole manifestation of immune deficiency and to determine their response to the 23-valent pneumococcal vaccine.
RESULTS: Of 100 children with low pneumococcal antibody titers, 87 generated a protective antibody response to the pneumococcal vaccine (> 300 ng/mL to the majority of the antigen serotypes), while 13 responded poorly or not at all. Repeated vaccination of nonresponders failed to produce a normal response.
CONCLUSION: We have identified two clinically distinct subpopulations of children with recurrent respiratory infections characterized by their responsiveness to pneumococcal antigens: one group did not respond to pneumococcal vaccination, whereas the other group responded both clinically and serologically. The nonresponding 6.5% subpopulation has an apparent isolated defect in anti-pneumococcal antibody production associated with recurrent respiratory infections despite normal IgG2 subclass levels.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7648376

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  15 in total

Review 1.  T lymphocyte dependence of the antibody response to 'T lymphocyte independent type 2' antigens.

Authors:  A Jeurissen; J L Ceuppens; X Bossuyt
Journal:  Immunology       Date:  2004-01       Impact factor: 7.397

2.  Characterization of specific antibody deficiency in adults with medically refractory chronic rhinosinusitis.

Authors:  Tara F Carr; Alan P Koterba; Rakesh Chandra; Leslie C Grammer; David B Conley; Kathleen E Harris; Robert Kern; Robert P Schleimer; Anju T Peters
Journal:  Am J Rhinol Allergy       Date:  2011 Jul-Aug       Impact factor: 2.467

3.  Association of CD14 promoter polymorphism with otitis media and pneumococcal vaccine responses.

Authors:  S P Wiertsema; S-K Khoo; G Baynam; R H Veenhoven; I A Laing; G A Zielhuis; G T Rijkers; J Goldblatt; P N Lesouëf; E A M Sanders
Journal:  Clin Vaccine Immunol       Date:  2006-08

4.  The clinical syndrome of specific antibody deficiency in children.

Authors:  R J Boyle; C Le; A Balloch; M L-K Tang
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

5.  Atopic eczema is associated with delayed maturation of the antibody response to pneumococcal vaccine.

Authors:  P D Arkwright; L Patel; A Moran; M R Haeney; C I Ewing; T J David
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

6.  Value of allohaemagglutinins in the diagnosis of a polysaccharide antibody deficiency.

Authors:  H Schaballie; F Vermeulen; B Verbinnen; G Frans; E Vermeulen; M Proesmans; K De Vreese; M P Emonds; K De Boeck; L Moens; C Picard; X Bossuyt; I Meyts
Journal:  Clin Exp Immunol       Date:  2015-05       Impact factor: 4.330

Review 7.  [Classification and diagnosis of immunodeficiency syndromes].

Authors:  K Warnatz; H-H Peter
Journal:  Internist (Berl)       Date:  2004-08       Impact factor: 0.743

Review 8.  Otitis media as a presenting complaint in childhood immunodeficiency diseases.

Authors:  Nevin W Wilson; Mary Beth Hogan
Journal:  Curr Allergy Asthma Rep       Date:  2008-11       Impact factor: 4.806

9.  Prophylactic Antibiotics Versus Immunoglobulin Replacement in Specific Antibody Deficiency.

Authors:  An L Nguyen; Gregory Constantine; Carleigh Kutac; Maha N Syed; Jordan S Orange; Kathleen E Sullivan
Journal:  J Clin Immunol       Date:  2019-11-22       Impact factor: 8.317

10.  Specific antibody deficiency in children with recurrent respiratory infections: a controlled study with follow-up.

Authors:  O Ruuskanen; A Nurkka; M Helminen; M K Viljanen; H Käyhty; L Kainulainen
Journal:  Clin Exp Immunol       Date:  2013-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.